INTRODUCTION
The HBV virus is a carcinogen. It induces hepatocellular carcinoma, which is among the top-five most-frequent cancers in the population. The virus leads to liver cirrhosis and failure. Researchers continue to seek specific markers used for disease progression assessment and the determination of the inflammation course (the so-called staging). Recently, a few studies have pointed to the importance of the NLR as a potential predictive factor for chronic hepatitis B progression and liver failure [1] . Attention was drawn to the possibility of predicting acute-on-chronic hepatitis B using the NLR in patients with the disease which were not necessarily caused by the virus [2] . There are reports which describe the use of the NLR as a predictive factor of mortality in patients with acute-on-chronic HBV [3] . The neutrophil-to-lymphocyte ratio (NLR) is used as a simple, cheap and readily accessible marker for the assessment of the condition of patients with chronic and oncological diseases. Recently, several reports have noted that the NLR can also prove useful to predict the disease progression in the case of chronic hepatitis B. In chronic hepatitis B, the NLR was evaluated in this study as a predictive factor for hepatic fibrosis and steatosis. Attempts were made to introduce the NLR into the diagnostics and monitoring of such diseases as Hodgkin's lymphoma [4, 5, 6] , diffuse large B-cell Lymphoma [7] , gastric cancer or acute venous thrombosis [8, 9, 10, 11] . Furthermore, everyday clinical practice is faced with the so-far underestimated problem of liver steatosis. The literature still lacks consistent data concerning fatty liver in patients with HBV, yet most of the papers show that HBV patients display less advanced stages of steatosis than the non-infected population [12, 13, 14] . Hence the subject of this study, the aim of which was to determine whether NLR values are significantly varied in HBV patients and healthy individuals. Furthermore, it attempts to show whether there is a correlation between the NLR and hepatic fibrosis or steatosis in HBV patients. MPV is a parameter which relates to the standard CBC test. Hence it is easily accessible, replicable, and cheap. The evaluation of MPV levels is usually overlooked in clinical practice. However, the source literature provides several examples which stress the importance of this parameter and suggest that it is correlated with the disease's severity [15, 16] .
OBJECTIVE
Evaluation of the neutrophil-lymphocyte ratio as a predictor for liver fibrosis and steatosis in non-treated patients with chronic hepatitis B.
MATERIALS AND METHOD

This retrospective study was conducted in 2017 at the Department of Infectious Diseases of Independent Public
Hospital No 1 of the Medical University in Lublin, eastern Poland. It involved patients with newly diagnosed chronic HBV in whom HBs antigen and anti-HBe and HBV DNA had been found. The study comprised patients with CHB who had commenced antiviral treatment. HAV, HCV and HIV infections were ruled out. The patients with cardiovascular, respiratory, endocrine and renal problems, or neoplastic processes, were excluded from the study. Patients with BMI greater than 25 were also excluded. None of the patients smoked cigarettes or abused alcohol, according to the criteria of the Dietary Guidelines for Americans for the years 2015-2020.
Study group characteristics: the average age of the patients was 48.2(±12); women constituted 48% of the study group and men 52%; the control group comprised 20 healthy individuals with an average age of 42.1 (±); women constituted 40% of the control group and men 60%.
Transient Elastography (TE) was conducted by two qualified researchers. Blood for CBC was collected on the same day. The level of fibrosis and steatosis, as well as the controlled attenuation parameter, were measured simultaneously using transient elastography with a medium-sized probe. Normal range for MPV -8-11.9 fl.
MS Office 2007 suite and Statistica v. 10.0 software by StatSoft were used for statistical analysis of the gathered results. Moreover, mean, median and maximum and minimum values were provided for the statistical description of the results. Normal distribution compliance was checked with the Shapiro-Wilk test.
Comparative analysis for the examined variables was conducted using the non-parametric U Mann-Whitney statistical test for two trials. The correlations between particular variables were described with the use of the Spearman correlation test. The identified differences were considered statistically significant at the significance level of p < 0.05.
RESULTS
The study showed a statistically significant negative correlation between fibrosis and NLR in HBV patients who had not yet received antiviral treatment. Additionally, a considerable difference in the NLR value was determined in the control group, in which it amounted to 1.2. In the study group, the NLR value was 1.6. The mean steatosis level was 255 dB/m and remained at the S2 level (17) . No relationship was found between the steatosis (CAP) and the NLR level (Tab.1; Fig. 1 ). The mean MPV was 12.6fl (±3.1), and was considerably higher in the CBH patients than in the control group. A positive correlation (r= 0.79; p= 0.001) was found between MPV and disease severity evaluated with transient elastography (Tab. 2; Fig. 2) . No relationship was identified between MPV levels and liver steatosis. 
DISCUSSION
The most relevant result of the study showed the difference in NLR values between the control and study groups, and the presence of a statistically significant reverse correlation (p=0.05) between the NLR levels and liver fibrosis, which were assessed with a non-invasive, state-of-the-art method used in hepatology. These observations are consistent with the studies by B. Yilmaz et al. [18] . They showed that there is a possibility to use NLR as a predictive factor of liver fibrosis in inactive hepatitis B carriers. Attention was also drawn to the fact that the NLR assessment should be applied together with other non-invasive markers. A group of researchers led by Peng has presented the usefulness of NLR in patients with NAFLD. They obtained a negative correlation between NLR and liver fibrosis in patients with HBV [19] . Another group of scientists stated that the cut-off value for NLR, which is the same or lower than 2.36, was predictive of a lower mortality rate among patients with acute CHB, and that a value higher than 6.12 could be treated as a warning against a higher risk Fibr of death [3] . The patients included in the presented study were not at risk of liver failure, which was confirmed by a Fibroscan examination. Similar to the work by H. Liu et al, the current study found a negative correlation between NLR and disease aggravation [3] . J. Gong et al. presents results consistent with the presented observations, indicating that NLR is reversely correlated with disease aggravation [11] . Higher values of this marker were observed in more severely sick patients. Morover, this indicator can be used as predictor of mortality from liver failure in the course of chronic severe hepatitis B.
The current study demonstrates that there is no correlation between NLR and liver steatosis. In 2015, H. Yilmaz et al. published a study which indicated that NLR could act as a very good predictive factor of fibrosis in non-alcoholic steatohepatitis [20] . The source literature lacks study results which would show a correlation between NLR and the level of steatosis. N. Moreau et al quotes researchers arguing that NLR value is not linked to disease severity in HBV patients, and emphasises that NLR should be treated as an independent non-invasive predictive marker [2] . Moreover, MPV values were significantly higher in the CHB patients than in the individuals in the control group. A positive correlation was found between MPV and disease severity evaluated with transient elastography. This result is similar with the results of E. Karagoz and P. Ye [15, 16] .
CONCLUSIONS
The NLR value is higher in HBV patients than in healthy individuals. It can be used as a predictive factor of disease severity in patients with chronic HBV. NLR has more value in combination with transient elastography assessment.
Abbreviations:
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